medigraphic.com
ISSN 0016-3813 (Print)

2003, Number s4

<< Back Next >>

Gac Med Mex 2003; 139 (s4)

Menopause and Cardiovascular Disease.

Goldzieher JW

Language: Spanish
References: 14
Page: 15-20
PDF size: 50.79 Kb.


Text Extraction

No abstract


REFERENCES

  1. Dubey RK, Jackson EK. Estrogen-induced cardiorenal protection. Am J Physiol Renal Physiol 2001;280:F365-F388.

  2. Bush TL, Barret-Connor E. Noncontraceptive estrogen use and cardiovascular disease. Epidemiol Rev 1985;7:80-104.

  3. Mendelsohn ME, Karas RH. The protective effects of estrogen on the cardiovascular system. N Engl J Med 1999;340:1801-1811.

  4. Clarkson TB, Adams MR, Kaplan JR, Sively CA, Koretnik DR. From menarche to menopause: coronary artery atherosclerosis and protection in cynomolgus monkeys. Am J Obstet Gynecol 1989;160:1280.

  5. Clarkson TB. Progestogens and cardiovascular disease. J Reprod Med 1999;44:180-184.

  6. Stampfer MJ, Coditz GA. Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Preventive Med 1991;20:47-63.

  7. Gordstein F, Stampfer MJ, Manson JE, Colditz GA, Willet WC, Rosner B, Speizer FE, Hennekens CH. Postmenopausal estrogen and progestin use and the risk of cardiovascular disease. N Engl J Med 1996;335:453-461.

  8. Writing Group for WHI: Risks and benefits of estrogen plus progestin in healthy postmenopausal women. JAMA 2002;288:321-333.

  9. Hong MK, Romm PA, Reagan K, Green CE, Rackley CE. Effects of estrogen replacement therapy on serum lipid values and angiographically defined coronary artery disease in postmenopausal women. Am J Cardiol 1992;69:176-178.

  10. Sullivan JM, Vender Zwaag R, Hughes JP, Maddock V, Kroetz FW, Ramanathan KB, Mirvis DM. Estrogen replacement and coronary artery disease. Effect on survival in postmenopausal women. Arch Int Med 1990;150:2557-2562.

  11. Sullivamn JM, El-Zeky F, Vander Zwaag R, Ramanathan KB. Effect on survival of estrogen replacement therapy after coronary artery bypass grafting. Am J Cardiol 1997;79:847-850.

  12. Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, Vittinghoff E. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women (HERS). JAMA 1998;280:605-613.

  13. Bush T. Beyond HERS: Some (not so) random thought on randomized clinical trial. Int J Fertil 2001;46:55-59.

  14. Mendelsohn ME, Karas RH. The time has come to stop letting the HERS tale wag the dogma. Circulation 2001;104:2256-2259.




2020     |     www.medigraphic.com